Page last updated: 2024-10-30

lansoprazole and Myocarditis

lansoprazole has been researched along with Myocarditis in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vlahos, NP1
Vavilis, GK1
Giannelou, AG1
Georgopoulou, CN1
Kommata, VJ1
Kougias, CT1
Tsartsalis, DN1
Kounis, GN1
Mazarakis, A1
Batsolaki, M1
Gouvelou-Deligianni, GV1
Hahalis, G1
Kounis, NG1

Other Studies

1 other study available for lansoprazole and Myocarditis

ArticleYear
Hypersensitivity to proton pump inhibitors: lansoprazole-induced Kounis syndrome.
    International journal of cardiology, 2009, May-29, Volume: 134, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Drug Hypersensitivity; Humans; Lansoprazole; Male; Middle A

2009